GlassScriptPhysician profile
Stephen C Gillard
NPI 1437166881
$7,913.00
in general payments reported to CMS, 2019-2025
54 companies · $1,901 in 2025
The $1,901 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $752 · 2020: $500 · 2021: $832 · 2022: $957 · 2023: $1,403 · 2024: $1,567 · 2025: $1,901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,777 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,777.37 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $806.70 | 2019-2025 | Erleada, Akeega, Balversa |
| Astellas Pharma US INC | $750.53 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $476.16 | 2019-2025 | Provenge |
| Dentsply Ih Ab | $372.11 | 2023-2024 | Lofric, Lofric |
| Boston Scientific Corporation | $362.92 | 2019-2025 | Advantage System, Upsylon |
| Ferring Pharmaceuticals INC. | $356.41 | 2024-2025 | Adstiladrin |
| Immunitybio, INC. | $345.53 | 2024-2025 | |
| Procept Biorobotics Corporation | $332.17 | 2021-2025 | |
| Convatec INC. | $326.27 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $275.62 | 2021-2024 | Pylarify |
| Endo USA, INC. | $248.66 | 2024-2025 | Xiaflex, Aveed |
| Pfizer INC. | $232.38 | 2019-2025 | |
| Antares Pharma, INC. | $222.50 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Abbvie INC. | $214.62 | 2019-2025 | |
| 180 Medical, INC. | $211.84 | 2019-2025 | Gentlecath, Gentlecath Glide |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Gillard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.